Globe Life (NYSE: GL) revenue
Globe Life reported revenue of $5,994m for fiscal 2025, 3.7% more than in fiscal 2024 ($5,778m). Since fiscal 2016 its revenue has grown by 52.3%, an average growth of 4.8% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $5,994m | +3.7% | $1,436m | 24.0% |
| 2024 | $5,778m | +6.1% | $1,327m | 23.0% |
| 2023 | $5,448m | +4.2% | $1,265m | 23.2% |
| 2022 | $5,227m | +2.2% | $1,186m | 22.7% |
| 2021 | $5,112m | +7.9% | $1,227m | 24.0% |
| 2020 | $4,738m | +4.6% | $905.4m | 19.1% |
| 2019 | $4,528m | +5.2% | $920.1m | 20.3% |
| 2018 | $4,304m | +3.6% | $870.6m | 20.2% |
| 2017 | $4,156m | +5.6% | $821.2m | 19.8% |
| 2016 | $3,935m | — | $787.3m | 20.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Globe Life
- How much revenue did Globe Life make in fiscal 2025?
- Globe Life reported revenue of $5,994m for fiscal 2025, compared with $5,778m in fiscal 2024.
- How much has the revenue of Globe Life grown?
- Between fiscal 2016 and fiscal 2025 it went from $3,935m to $5,994m: 52.3% more, an average growth of 4.8% a year.
- What was the best year for revenue at Globe Life?
- Of its last 10 fiscal years, fiscal 2025, with $5,994m.
- Where do the figures for Globe Life come from?
- From the annual report (Form 10-K) that Globe Life files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Globe Life files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Globe Life: the Globe Life page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.